MCPHS and Sanofi are pleased to offer numerous Post PharmD Fellowship positions and are currently screening and scheduling interviews.

MCPHS / Sanofi

PROGRAM GOALS

The pharmaceutical industry is responsible for monitoring, assessing, and communicating safety information throughout a product’s lifecycle. At Sanofi, the Patient Safety & Pharmacovigilance (PSPV) Department is responsible for these activities. The aim of pharmacovigilance is to enhance patient care and safety in relation to the use of pharmaceutical products by ensuring a favorable benefit-risk profile. Pharmacovigilance is a thriving field within the pharmaceutical industry. As regulations continue to expand, the need for knowledgeable and qualified personnel increases.

PRIMARY OBJECTIVES

• Understand the mission of a pharmacovigilance department and the role of Patient Safety & Pharmacovigilance in clinical development and product lifecycle management.
• Become knowledgeable in current pharmacovigilance regulations and guidelines, including those in the US and Europe.
• Develop the ability to think strategically with a global pharmacovigilance and regulatory perspective.
• Enhance the ability to critically evaluate, interpret, synthesize, and present safety data in a clear and concise manner through written and verbal communication.
• Expand medical knowledge of products within various therapeutic areas (e.g. Rare Diseases, Multiple Sclerosis, Immunology, Vaccines, and Oncology).

View the Sanofi Program Brochure for more information, or visit http://www.mcphs.edu/pharmdfellow for general program information. In addition, see all of our Sanofi and other MCPHS Fellowship Program offerings here.

APPLICATION PROCEDURE

To be considered for an interview, please complete a fellowship application on the MCPHS SMApply application portal. Visit https://mcphs.smapply.io/

Please DO NOT request an interview within PPS. Our recruitment teams will contact qualified candidates via email to schedule interviews. 

The MCPHS application portal will open up on Monday, October 7, 2024. Applicants must upload the following application materials to the online portal by Monday, November 4, 2024:

• Letter of intent (addressed to the company specific program director/lead; found in each company brochure)
• Curriculum vitae
• Unofficial college transcript
• Contact information for three references. References will receive an electronic recommendation form to complete separately.

Incomplete applications WILL NOT be reviewed. Interviews CANNOT be scheduled until these materials have been submitted. Please keep in mind that this is a competitive process and applicants are encouraged to complete their applications as soon as possible. 

Recommendations

Three recommendation evaluation forms must be submitted no later than November 20, 2024via the online portal. This is NOT a letter of recommendation but an online form that the reference will need to complete.

Application Review and Interview Timeline

Following a review of submitted applications, pre-screens and preliminary interviews will begin in October. Additional interviews, including final rounds will take place in December during ASHP. Candidates will be notified if selected for an interview. The process is rigorous and competitive; therefore, candidates should submit their applications well in advance of posted deadlines as priority will be given to those who apply early.

ASHP Midyear & Onsite Interviews

The fellowship program will be conducting in-person interviews at the ASHP Midyear Clinical Meeting in New Orleans, LA. Attendance is strongly encouraged, but not required. Candidates attending in-person will not be able to interview without registering for both ASHP and PPS. Please refer to the ASHP & PPS website for registration details.

Top candidates may be invited for interviews at the sponsoring company’s location.

AIFA First Offer Date

The choice of a Post-Doctoral Fellowship is an important decision. MCPHS, in conjunction with the Alliance of Industry Fellowship Associates (AIFA), has aligned to extend offers for Fellowships no earlier than December 16, 2024. We believe this is a positive reflection of the cultures our Programs offer, and that culture is a critical consideration in choice of Fellowship. We hope that other academic and non-academic Fellowship Programs will NOT pressure candidates to accept offers prior to this aligned offer date.

We see this respect for candidate choice as a common aspect of each of our Program's cultures. We hope that other academic and non-academic Fellowship Programs will respect this timeline.

Onboarding

Final candidates will be required to go through additional screening / onboarding as required by MCPHS.

Eligibility

The MCPHS Biopharmaceutical Industry fellows will be selected on a nationally competitive basis.

• Applicants must have a Doctor of Pharmacy degree from an ACPE accredited college of pharmacy at the commencement of the program.
• Candidates must have strong written and verbal communication skills and a strong interest in pursuing a career within the biopharmaceutical industry.
• All candidates must have authorization to work in the United States throughout the duration of the one or two year fellowship. No visa sponsorship will be provided (i.e., TN, H-1B, STEM OPT, etc.).

Visit our website for more information: http://www.mcphs.edu/pharmdfellow

About MCPHS/Sanofi

Sanofi is an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Sanofi’s global specialty care business unit focuses on rare diseases, rare blood disorders, neurology, immunology, and oncology. Its approach is shaped by a long history of developing highly specialized treatments and forging close relationships with physician and patient communities. Our cutting-edge science and manufacturing, fueled by data and digital technologies, have the potential to transform the practice of medicine for millions of people around the world.

Connections working at MCPHS/Sanofi